You are now viewing 1 - 10 of 24 results
October 1, 2012 | Journal Article
This study examines how different drug plan benefit and formulary designs influence the selection of generic drugs to treat high cholesterol among Medicare beneficiaries.
May 1, 2012 | Journal Article
Value-based insurance design bases cost sharing on a medication's clinical value, not its price. This study shows the effectiveness of value-based insurance design.
November 1, 2010 | Journal Article
A large value-based insurance design program offered by Blue Cross Blue Shield of North Carolina eliminated generic medication copayments and reduced copayments for brand-name medications.
December 1, 2003 | Program Result
During 2002 and 2003, the Neighborhood Health Clinic in Naples, Fla. created a new state-of-the-art Medication Room to improve the delivery of medications to its 12,000 clients.
January 1, 2001 | Program Result
During the 1980s, expenditures on pharmaceuticals nationwide increased by 152 percent. HMOs implemented a number of cost-control mechanisms to slow the rate of growth of pharmaceutical expenditures, and were successful in doing so compared to fee-for-service health plans.
March 6, 2008 | Program Result
Researchers at Brandeis University used data from two state-run prescription drug programs for low-income seniors to examine how differences in prescription drug coverage affect enrollment, drug use and spending in state programs.
July 31, 2008 | Program Result
Pharmacogenomics is the study of how inherited variations in genes dictate a person's reaction to a drug. Louis F. Rossiter, PhD, and other researchers examined how pharmacogenomics fits within the current health care market.
April 19, 2012 | Journal Article
New report examines the impact of the Medicare Modernization Act on access to cancer chemotherapy treatment.
August 1, 2011 | Journal Article
Higher medication adherence rates for two classes of drugs saved Medicare dollars over three years.
June 1, 2011 | Journal Article
A decrease in prescription length and an increase in brand-name co-payment decreased medication adherence in North Carolina.